- Home
- KPTI vs MPAA Comparison
KPTI vs MPAA Comparison
Compare KPTI & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | MPAA |
|---|---|---|
| Founded | 2008 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.8M | 208.6M |
| IPO Year | 2013 | 2007 |
Fundamental Metrics
Financial Performance| Metric | KPTI | MPAA |
|---|---|---|
| Price | $9.21 | $15.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $16.00 | ★ $17.50 |
| AVG Volume (30 Days) | ★ 339.8K | 129.6K |
| Earning Date | 05-04-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 162.63 |
| EPS | N/A | ★ 0.62 |
| Revenue | $146,067,000.00 | ★ $789,806,000.00 |
| Revenue This Year | N/A | $1.50 |
| Revenue Next Year | $22.36 | $7.42 |
| P/E Ratio | ★ N/A | $24.77 |
| Revenue Growth | 0.57 | ★ 4.28 |
| 52 Week Low | $3.65 | $9.29 |
| 52 Week High | $10.99 | $18.12 |
Technical Indicators
Market Signals| Indicator | KPTI | MPAA |
|---|---|---|
| Relative Strength Index (RSI) | 51.28 | 71.56 |
| Support Level | $5.40 | $14.48 |
| Resistance Level | $9.45 | $16.62 |
| Average True Range (ATR) | 0.73 | 0.90 |
| MACD | 0.00 | 0.34 |
| Stochastic Oscillator | 32.96 | 94.77 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.